Study: Hormone choice may be link to breast cancer

04/7/2005 | NYTimes.com

Recurring breast cancer may be linked to which hormones are prescribed for women after menopause, scientists report. A Swedish study showed hormone therapy concentrating on estrogen produced no increase in breast cancers, while an earlier study found the combination of estrogen and progestogen produced an increased risk of recurring cancer for women who had been diagnosed with early-stage breast cancer.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC